Aziridinium Ion Ring Opening for Regioselective Drug Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The reactivity and synthetic applications of aziridinium ions are hindered by difficulties in isolation and characterization, and there is a lack of general and efficient methods for synthesizing optically active aziridinium ions with functionalities, limiting their applications in drug synthesis.
Innovation Solution
A process for stereoselective and regioselective ring opening reactions of aziridinium ions is developed, involving the conversion of substituted amino alcohols to aziridinium ions, which are then reacted with nucleophiles to produce key precursor molecules for pharmaceuticals, such as Phenibut, Tryptamine, and Selegiline, using catalysts like Lewis acids and organocatalysts in situ reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If aziridinium ions are used as reactive intermediates in asymmetric synthesis, then synthetic utility and biological activity are improved, but difficulties in isolation and characterization hinder their application
Solution Approach 1:
The patent performs nucleophilic ring opening reactions of aziridinium ions immediately after their formation without isolating the intermediate. The aziridinium ions are generated in situ from amino halides and directly reacted with nucleophiles, eliminating the need for isolation and characterization steps while maintaining synthetic utility
Solution Approach 2:
The patent uses amino halides as stable precursors that can be isolated and stored, then converted to reactive aziridinium ions in situ. This intermediary approach allows handling of stable compounds while accessing the reactivity of unstable intermediates
2Productivity
If conventional methods are used for synthesis of pharmaceutical compounds, then isolation and purification steps can be performed, but reaction steps are numerous and yields are lower
Solution Approach 1:
The patent combines multiple synthetic steps into a one-pot sequential reaction where amino alcohol is converted to amino halide, then to aziridinium ion, and finally the nucleophilic ring opening occurs all in one reaction vessel without intermediate isolation or purification steps
Solution Approach 2:
The patent maintains continuous reaction progression where each step's product immediately becomes the next step's reactant without interruption for isolation or purification, maximizing productivity and minimizing manufacturing complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the efficient synthesis of pharmaceutical compounds with higher yields and reduced purification processes, facilitating their use in cancer imaging, radioimmunotherapy, Parkinson's disease treatment, and other therapeutic applications.
Implementation Method 1
nucleophilic ring opening reactions of aziridinium ions
Implementation Method 2
stereoselective and regioselective reaction with a nucleophile
Implementation Method 3
using catalysts like Lewis acids and organocatalysts in situ reactions
Data Source
AI summary
Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.